FDA considered the planned HER-096 Phase 2a study design appropriateStudy design finalized; approximately 100 patients to be enrolledMore than 50% of Phase 2 funding secured or identifiedEspoo, ...
Quotient Sciences today announces the successful initiation of a clinical study evaluating a novel drug product developed ...
Biological products, or biologics, are large, complex molecules produced in living systems such as therapeutic proteins, antibodies, and gene- or cell-based therapies. Under the Public Health Service ...
Zacks Small Cap Research on MSN
AINMF: Company encouraged by rising interest in leveraging AI to improve & derisk clinical trial activity
By M. Marin OTCQB: AINMF READ THE FULL AINMF RESEARCH REPORT AINMF believes platform is well-positioned, as use of AI in clinical development is expected to rise NetraMark (OTCQB: AINMF), an AI ...
Late-stage productivity improved in 2025, but total clinical development duration rose to 10 years, indicating non-structural ...
Diagnostic test developers, including clinical laboratories, responded to the COVID-19 pandemic with inspiring creativity to meet patient testing needs. These developers found unique ways to enable ...
Recent Trends and Patient Outcomes of Phase I Trials: A Single-Institution Experience in the Era of New Therapeutic Agents This study reviewed all industry-sponsored phase I clinical trial protocols ...
Simulations of a real-world explanatory trial of transarterial radioembolization for advanced unresectable hepatocellular carcinoma with portal vein invasion were performed to examine the effects of ...
A common thread in your work has been connecting people to clinical trials. Was that the focus in founding the CARE Research Center? The impetus behind the CARE Research Center is probably not so ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results